发明名称 LONG-TERM IN VIVO TRANSGENE EXPRESSION
摘要 Efficient and prolonged hCFTR expression is one of the major obstacles for cystic fibrosis lung therapy. hCFTR mRNA expression levels depend on eukaryotic expression cassette components, prokaryotic backbone elements, and the gene transfer method may also influence transcriptional silencing mechanisms. A codon-optimized and CpG-reduced human CFTR gene (CO-CFTR) was made. Various vector modifications were tested to facilitate extended duration of CO-CFTR expression. Insertion of an extended 3′BGH transcribed sequence (712 bp) in an inverted orientation produced prolonged expression of CO-CFTR expression at biologically relevant levels. Further studies revealed that prolonged CO-CFTR expression is dependant on the orientation of the extended BGH 3′ BGH transcribed sequence and its transcription, is not specific to the UbC promoter, and is less dependent on other vector backbone elements.
申请公布号 US2010203627(A1) 申请公布日期 2010.08.12
申请号 US20080676426 申请日期 2008.09.12
申请人 COPERNICUS THERAPEUTICS, INC. 发明人 COOPER MARK J.;PADEGIMAS LINAS
分类号 C12N15/63;C12N15/18 主分类号 C12N15/63
代理机构 代理人
主权项
地址